Chiesi Ventures

Chiesi Ventures operates as a venture capital firm, investing in companies pioneering novel therapies and technologies. Its strategic focus centers on early-stage companies developing treatments for rare and orphan disorders, aligning with the broader Chiesi Group's commitment to specialized therapeutic areas. The firm advances innovative solutions across small molecules, biologics, advanced therapies, and disease management.

Chiesi Ventures was established in 2014 by Giacomo Chiesi, who serves as Managing Partner. This venture arm originated as a joint initiative with Pappas Capital, driven by an insight to strategically invest in external innovation, complementing the pharmaceutical development interests of the Chiesi Group. The parent company, a global biopharmaceutical entity, was founded in 1935 by Giacomo Chiesi's grandfather.

The firm primarily supports emerging biotechnology and pharmaceutical companies working on solutions for patients with rare diseases. Chiesi Ventures is dedicated to fostering an ecosystem of innovation aimed at addressing unmet medical needs. Its long-term vision is to accelerate transformative treatment development, ultimately benefiting patients with limited therapeutic options.